Hepatorenal syndrome primary prevention: Difference between revisions
Jump to navigation
Jump to search
Sunny Kumar (talk | contribs) |
|||
| Line 7: | Line 7: | ||
==Primary Prevention== | ==Primary Prevention== | ||
There is no primary prevention of hepatorenal syndrome. Albumin reduces development of renal failure in patients having liver disease.<ref name="pmid10432325">{{cite journal| author=Sort P, Navasa M, Arroyo V, Aldeguer X, Planas R, Ruiz-del-Arbol L et al.| title=Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. | journal=N Engl J Med | year= 1999 | volume= 341 | issue= 6 | pages= 403-9 | pmid=10432325 | doi=10.1056/NEJM199908053410603 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10432325 }}</ref> | There is no primary prevention of hepatorenal syndrome. [[Albumin]] reduces development of [[Renal insufficiency|renal failure]] in patients having [[Liver diseases|liver disease]].<ref name="pmid10432325">{{cite journal| author=Sort P, Navasa M, Arroyo V, Aldeguer X, Planas R, Ruiz-del-Arbol L et al.| title=Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. | journal=N Engl J Med | year= 1999 | volume= 341 | issue= 6 | pages= 403-9 | pmid=10432325 | doi=10.1056/NEJM199908053410603 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10432325 }}</ref> | ||
==References== | ==References== | ||
Latest revision as of 15:07, 22 December 2017
|
Hepatorenal syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Hepatorenal syndrome primary prevention On the Web |
|
American Roentgen Ray Society Images of Hepatorenal syndrome primary prevention |
|
Risk calculators and risk factors for Hepatorenal syndrome primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sunny Kumar MD [2]
Overview
There is no primary prevention of hepatorenal syndrome.
Primary Prevention
There is no primary prevention of hepatorenal syndrome. Albumin reduces development of renal failure in patients having liver disease.[1]
References
- ↑ Sort P, Navasa M, Arroyo V, Aldeguer X, Planas R, Ruiz-del-Arbol L; et al. (1999). "Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis". N Engl J Med. 341 (6): 403–9. doi:10.1056/NEJM199908053410603. PMID 10432325.